InSilico Medicine
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
InSilico Medicine is currently valued at N/A as of May 8, 2025. The company has raised a total of $549.3M in funding.
Investment Perspective
InSilico Medicine's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is InSilico Medicine Worth in 2025?
As of 2025, InSilico Medicine is valued at N/A, based on the company's IPO funding round in May 8, 2025. This valuation positions InSilico Medicine as one of the leading private companies in the sector.
InSilico Medicine Valuation History
InSilico Medicine's funding history demonstrates steady growth and investor confidence.
How InSilico Medicine Valuation is Determined
Private company valuations like InSilico Medicine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
InSilico Medicine Valuation FAQs
Is InSilico Medicine profitable?
InSilico Medicine has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does InSilico Medicine's valuation compare to competitors?
InSilico Medicine is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will InSilico Medicine IPO?
InSilico Medicine has not announced plans for an initial public offering. Until an IPO, investors can access InSilico Medicine shares through secondary market platforms.